- Home
- GOSS vs PKBK Comparison
GOSS vs PKBK Comparison
Compare GOSS & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PKBK
- Stock Information
- Founded
- GOSS 2015
- PKBK 1999
- Country
- GOSS United States
- PKBK United States
- Employees
- GOSS N/A
- PKBK N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PKBK Major Banks
- Sector
- GOSS Health Care
- PKBK Finance
- Exchange
- GOSS Nasdaq
- PKBK Nasdaq
- Market Cap
- GOSS 246.6M
- PKBK 245.5M
- IPO Year
- GOSS 2019
- PKBK N/A
- Fundamental
- Price
- GOSS $1.07
- PKBK $20.26
- Analyst Decision
- GOSS Strong Buy
- PKBK
- Analyst Count
- GOSS 5
- PKBK 0
- Target Price
- GOSS $9.20
- PKBK N/A
- AVG Volume (30 Days)
- GOSS 989.6K
- PKBK 23.4K
- Earning Date
- GOSS 11-07-2024
- PKBK 10-23-2024
- Dividend Yield
- GOSS N/A
- PKBK 3.55%
- EPS Growth
- GOSS N/A
- PKBK N/A
- EPS
- GOSS N/A
- PKBK 1.80
- Revenue
- GOSS $95,842,000.00
- PKBK $64,605,999.00
- Revenue This Year
- GOSS N/A
- PKBK N/A
- Revenue Next Year
- GOSS N/A
- PKBK N/A
- P/E Ratio
- GOSS N/A
- PKBK $11.27
- Revenue Growth
- GOSS N/A
- PKBK N/A
- 52 Week Low
- GOSS $0.45
- PKBK $15.16
- 52 Week High
- GOSS $1.60
- PKBK $22.00
- Technical
- Relative Strength Index (RSI)
- GOSS 62.64
- PKBK 45.43
- Support Level
- GOSS $0.98
- PKBK $20.19
- Resistance Level
- GOSS $1.07
- PKBK $21.03
- Average True Range (ATR)
- GOSS 0.07
- PKBK 0.44
- MACD
- GOSS 0.01
- PKBK -0.17
- Stochastic Oscillator
- GOSS 83.26
- PKBK 3.87
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.